Cargando…
A surrogate-based approach for post-genomic partner identification
BACKGROUND: Modern drug discovery is concerned with identification and validation of novel protein targets from among the 30,000 genes or more postulated to be present in the human genome. While protein-protein interactions may be central to many disease indications, it has been difficult to identif...
Autores principales: | Pillutla, Renuka C, Hsiao, Ku-chuan, Brissette, Renee, Eder, Paul S, Giordano, Tony, Fletcher, Paul W, Lennick, Michael, Blume, Arthur J, Goldstein, Neil I |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC57814/ https://www.ncbi.nlm.nih.gov/pubmed/11602024 http://dx.doi.org/10.1186/1472-6750-1-6 |
Ejemplares similares
-
Peptides identify multiple hotspots within the ligand binding domain of the TNF receptor 2
por: Hsiao, Ku-chuan, et al.
Publicado: (2003) -
Surrogate utility estimation by long-term partners and unfamiliar dyads
por: Tunney, Richard J., et al.
Publicado: (2015) -
Urea and protein carbamylation in ESRD: Surrogate markers or partners in crime?
por: Velasquez, Manuel T, et al.
Publicado: (2015) -
Inescapable Fibrosis: The Development of Desquamative Interstitial Pneumonia Post-Lung Transplantation Performed for a Patient with Idiopathic Pulmonary Fibrosis
por: Lilburn, Paul, et al.
Publicado: (2023) -
Moral intelligence for the entrepreneur
por: Lennick, Doug, et al.
Publicado: (2011)